-
Cardiology Month in Review: April 2024
02 May 2024 15:09 GMT
… 2024, the US Food and Drug Administration Abbott’s Esprit BTK … from the US Food and Drug Administration for treating tricuspid … for Greene include Amgen, AstraZeneca, Bayer Healthcare Pharmaceuticals, Boehringer Ingelheim Pharmaceuticals, Cytokinetics …
-
Twice-yearly injectable antihypertensive drug lowers BP at 6 months: KARDIA-2
07 Apr 2024 21:38 GMT
… .
The twice-yearly drug shows promise as part … adherence to complex, multi-drug oral treatment regimens may … addition of other antihypertensive drugs at 3 months to … grants from Alnylam, AstraZeneca, Bayer, Healthcare Pharmaceuticals, Novartis and Pfizer. …
-
Botanical And Plant Derived Drugs Market Is Booming Worldwide 2024-2031 | GlaxoSmithKline, Pfizer, Inc. Sanofi
29 Mar 2024 07:42 GMT
… the Botanical And Plant Derived Drugs industry, anticipates future growth … Segmentation and Top Companies Analysis :
◘ Bayer Healthcare
◘ GlaxoSmithKline
◘ Pfizer Inc. Sanofi
… the Botanical And Plant Derived Drugs market.
✦ Detailed Market Segmentation …
-
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
30 Apr 2024 11:30 GMT
… female sexual arousal disorder Bayer HealthCare holds the exclusive rights … to advance their internal drug candidate(s) or for … with a basket of drug products in development. Any … royalty rights associated with individual drug products in development. As …
-
Drug-drug interaction potential among patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) treated with novel androgen receptor inhibitors.
14 Mar 2024 09:19 GMT
… that increase the potential for drug-drug interactions (pDDIs). This study assessed …
Data Generation and Observational Studies, Bayer Healthcare, Whippany, NJ, USA., Market Access …
-
LASCO Pharmaceutical, Bayer launch drug to treat chronic kidney disease
12 Mar 2024 09:06 GMT
Bayer Healthcare, in partnership with LASCO Pharmaceutical … has introduced finerenone, a groundbreaking drug, branded as Firialta, for the … belonging to a class of drugs known as non-steroidal mineralocorticoid … Bayer to be launching this drug in Jamaica as we …
-
November 16, 2017: Meeting of the Antimicrobial Drugs Advisory Committee Meeting Announcement - 11/15/2017
08 Mar 2024 01:23 GMT
… new drug application (NDA) 209367, ciprofloxacin inhalation powder, sponsored by Bayer HealthCare … 2017 Meeting Materials, Antimicrobial Drugs Advisory Committee (formerly known as … the Anti-Infective Drugs Advisory Committee).
Public Participation …
-
Lasco, Bayer launch groundbreaking drug to treat kidney disease
06 Mar 2024 20:44 GMT
Bayer Healthcare, in partnership with LASCO … has introduced finerenone, a groundbreaking drug, branded as Firialta, for the … belonging to a class of drugs known as non-steroidal mineralocorticoid … and the benefits of the drug. Finerenone is indicated to …
-
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
05 Mar 2024 13:00 GMT
… The program was licensed from Bayer Healthcare and is a 5th generation … Akari has been granted Orphan Drug, Fast Track and Rare … HSCT-TMA and orphan drug designation from the European … Bio pipeline includes an antibody-drug-conjugate (ADC) platform that …
-
Akari Therapeutics and Peak Bio Announce Definitive Agreement to Merge as Equals Creating an Expanded Pipeline That Features a Novel Antibody Drug Conjugate (ADC) Toolkit
05 Mar 2024 13:00 GMT
… The program was licensed from Bayer Healthcare and is a 5th generation … Akari has been granted Orphan Drug, Fast Track and Rare … HSCT-TMA and orphan drug designation from the European … Bio pipeline includes an antibody-drug-conjugate (ADC) platform that …